Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma

Abstract Objective Disease-related weight loss is relatively common in patients with newly diagnosed multiple myeloma, but there are limited data about the impact of nutritional status on survival. Methods Using the Patient-Generated Subjective Global Assessment (PG-SGA) score, we retrospectively ex...

Full description

Saved in:
Bibliographic Details
Published inNutrition (Burbank, Los Angeles County, Calif.) Vol. 36; pp. 67 - 71
Main Authors Kim, Hae Su, M.D, Lee, Ji Yun, M.D, Lim, Sung Hee, M.D, Kim, Seok Jin, M.D, Jang, Jun Ho, M.D, Kim, Won Seog, M.D, Jung, Chul Won, M.D, Kim, Kihyun, M.D
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2017
Elsevier Limited
Subjects
Age
PS
BMI
WHO
MM
OS
ISS
HRs
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objective Disease-related weight loss is relatively common in patients with newly diagnosed multiple myeloma, but there are limited data about the impact of nutritional status on survival. Methods Using the Patient-Generated Subjective Global Assessment (PG-SGA) score, we retrospectively explored the effect of malnutrition on the survival of Asian patients with multiple myeloma. Results Two hundred sixteen myeloma patients were subdivided into three groups based on their PG-SGA scores. Twenty-three percent of patients (50/216) had PG-SGA scores ≥9, indicating severe malnutrition requiring specialist nutrition intervention. Body mass index and serum hemoglobin were independently associated with PG-SGA scores ( p <0.05). The median survival time was not reached in nourished patients with PG-SGA scores of 0-3, 58.7 months in moderately malnourished patients with PG-SGA scores of 4-8, and 35.0 months in severely malnourished patients with PG-SGA scores ≥9 ( p =0.001). Multivariate analysis revealed that PG-SGA scores ≥9 compared with PG-SGA scores of 0-3 (HR 2.347, 95% confidence interval [CI]: 1.271-4.334; p =0.006), International Staging System (ISS) stage III compared with ISS stage I (HR 2.360, 95% CI: 1.271-4.379, p =0.007) and autologous stem cell transplantation (HR 0.388, 95% CI: 0.248-0.606, p <0.001) were associated with overall survival. Conclusions A higher PG-SGA score prior to chemotherapy was associated with reduced survival among patients with multiple myeloma. Nutritional evaluation should be an integral part of the clinical assessment of MM patients, and the PG-SGA score would be an appropriate tool to evaluate nutritional status.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0899-9007
1873-1244
DOI:10.1016/j.nut.2016.06.009